Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Exact Sciences Corp (NASDAQ: EXAS) closed at $49.83 up 3.04% from its previous closing price of $48.36. In other words, the price has increased by $3.04 from its previous closing price. On the day, 2.56 million shares were traded. EXAS stock price reached its highest trading level at $50.46 during the session, while it also had its lowest trading level at $48.19.
Ratios:
For a deeper understanding of Exact Sciences Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.96 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.42. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.73. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $60.
On March 13, 2025, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $52.
On January 23, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $70.Barclays initiated its Overweight rating on January 23, 2025, with a $70 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 16 ’25 when Sebelius Kathleen bought 8,164 shares for $53.11 per share.
Zanotti Katherine S sold 3,207 shares of EXAS for $170,612 on Jun 13 ’25. The Director now owns 72,759 shares after completing the transaction at $53.20 per share. On Jun 13 ’25, another insider, Zanotti Katherine S, who serves as the Director of the company, bought 3,207 shares for $53.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 9399831552 and an Enterprise Value of 10875426816. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.32 while its Price-to-Book (P/B) ratio in mrq is 3.92. Its current Enterprise Value per Revenue stands at 3.845 whereas that against EBITDA is 285.504.
Stock Price History:
The Beta on a monthly basis for EXAS is 0.93, which has changed by 0.041379333 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, EXAS has reached a high of $72.83, while it has fallen to a 52-week low of $39.97. The 50-Day Moving Average of the stock is -7.89%, while the 200-Day Moving Average is calculated to be -8.51%.
Shares Statistics:
For the past three months, EXAS has traded an average of 2.87M shares per day and 2333710 over the past ten days. A total of 188.59M shares are outstanding, with a floating share count of 186.20M. Insiders hold about 1.29% of the company’s shares, while institutions hold 97.51% stake in the company. Shares short for EXAS as of 1751241600 were 7015295 with a Short Ratio of 2.44, compared to 1748563200 on 10667953. Therefore, it implies a Short% of Shares Outstanding of 7015295 and a Short% of Float of 4.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
